General Scientific Aspects of Personalised Medicine: The Healthcare Biotech Industry Perspective
On 19 March 2010, EuropaBio organised its first Workshop on personalised medicine entitled: General Scientific Aspects of Personalised Medicine: The Healthcare Biotech Industry Perspective. Attended by a large audience of policy-makers, regulators and industry experts, the workshop provided participants with an overview of the scientific aspects of personalised medicines including, among others, the role of genomics in the latest developments of personalised medical applications or the use of diagnostics in clinical development.
The presentations can be downloaded as follows:
- What personalised medicine is, by Prof. Thomas Weihrauch, Bayer Schering Pharma
- Genomics in Personalised medicine: Targeting medicines to the right patient, by Prof. Detlef Niese, Novartis
- Diagnostics and Biomarkers, by Tim Kievits, PamGene
- Rare diseases and orphan drugs as a precursor to personalised medicine: analogies between the two fields, by Wills Hughes-Wilson, Genzyme
For further information about this first workshop or follow-on events, please contact Ludovic Lacaine, Director, Healthcare Biotech.